MA
CNCE

MUFG Americas’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

MUFG Americas’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-69
Closed -$2K – 1039
2017
Q4 		$2K Sell
69
-186
-73% -$3.75K ﹤0.01% 978
2017
Q3 		$4K Sell
255
-165
-39% -$2.39K ﹤0.01% 975
2017
Q2 		$6K Hold
420
– – ﹤0.01% 919
2017
Q1 		$7K Hold
420
– – ﹤0.01% 899
2016
Q4 		$4K Sell
420
-942
-69% -$8.61K ﹤0.01% 962
2016
Q3 		$14K Sell
1,362
-925
-40% -$10.1K ﹤0.01% 789
2016
Q2 		$26K Buy
2,287
+2,077
+989% +$26.4K ﹤0.01% 650
2016
Q1 		$3K Sell
210
-100
-32% -$1.44K ﹤0.01% 1081
2015
Q4 		$6K Buy
+310
New +$6.74K ﹤0.01% 919

Other funds holding CNCE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MUFG Americas's CNCE Position: Q1 2018 in Review

MUFG Americas sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2018, closing a stake of 69 shares — an estimated $2K sold.

MUFG Americas first reported a position in CNCE in Q4 2015 and held it in 9 quarters. The position peaked at $26K in Q2 2016. 123 funds tracked by Wall St. Rank hold CNCE as of Q1 2018.

  • MUFG Americas reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • MUFG Americas sold 69 Concert Pharmaceuticals, Inc. shares in Q1 2018, an estimated $2K.
  • MUFG Americas first reported a position in Concert Pharmaceuticals, Inc. in Q4 2015 and held it in 9 quarters.
  • MUFG Americas's Concert Pharmaceuticals, Inc. position peaked at $26K in Q2 2016.
  • 123 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2018.

Based on MUFG Americas's 13F filing for Q1 2018, filed 7 May 2018.